No Data
No Data
Plasma, JINSHD, Koseido HD, etc.
Plunged. The company announced its financial results for the fiscal year ending in August 24 last weekend, with an operating profit of 1.47 billion yen, a decrease of 33.9% from the previous year. It fell slightly below the revised upward figure of 1.5 billion yen at the time of the third quarter financial results.
Active and newly listed stocks during the morning session.
*JINS HD <3046> 6160 +1000, significant overshooting in the previous period leads to increased dividends. *Kosaido HD <7868> 575 +80, positive sentiment towards the significant increase in first quarter profit announcement. *TSI HD <3608> 1069 +133, viewed as a positive factor with the announcement of share buyback. *Marumae <6264> 1687 +199, impact strengthened by the outlook of significant profit increase for the current period. *Bic Camera <3048> 1721 +191, both previous period performance and current outlook exceed consensus expectations.
Hot stocks digest (morning session): JINSHD, KOZAIDOH HD, Bic Camera, etc.
Cosmos Pharmaceuticals <3349>: ¥7,729 (+¥409) rebounded significantly. The company announced its first-quarter financial results last weekend, with an operating profit of ¥11.6 billion, a 28.8% increase from the same period last year, exceeding the market consensus by approximately ¥2 billion. The gross profit margin for general food has shown significant improvement. The unchanged full-year plan is ¥31.6 billion, a 0.3% increase from the previous year, with a significant upside potential. Additionally, the same-store sales for September that were simultaneously announced decreased by 4.2% compared to the same month last year.
Rakuten G, Asahi Kasei, etc. (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Former Changed After -------------------------------------------------- <3349> Cosmos Pharmaceuticals McCollie 'Out P' 'Neutral' Target Stock Price Changed Code Stock Name Securities Company Former Changed After -------------------------------------------------- <3349> Cosmos Pharmaceuticals
Cosmos Pharmaceuticals - Significant rebound, first quarter sees significantly higher profits than expected.
Cosmos Pharmaceuticals <3349> surged significantly. The company announced its first-quarter financial results over the weekend, with operating profit reaching 11.6 billion yen, a 28.8% increase compared to the same period last year, exceeding the market consensus by approximately 2 billion yen. The gross profit margin of general food products has shown a significant improvement. The unchanged full-year plan is set at 31.6 billion yen, a 0.3% increase from the previous year, with a significant potential for upward revision. Additionally, the same-store sales for September, announced simultaneously, decreased by 4.2% compared to the same month last year, marking the second consecutive month of decline.
October 15th [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] Cosmos Pharmaceuticals <3349> 7320 yen (10/11) A drugstore based in Kyushu. They announced their first quarter results. Operating profit increased by 28.8% year-on-year to 11.5 billion yen. Despite a temporary decline in profitability due to in-house competition, they carried out new store openings and expanded their store network to new business territories without hesitation. The operating profit for the fiscal year ending in May 2025 is expected to be 31.6 billion yen, a 0.3% increase from the previous period. The progress rate for the first quarter compared to the full-year forecast is 36.6%. The full-year forecast is for a slight increase in profit.
No Data
No Data